Skip to main content

Treatment in Criminal Justice Settings

  • Reference work entry
  • First Online:
Textbook of Addiction Treatment: International Perspectives

Abstract

The high prevalence of use among offenders is a consistent trend that transcends international boundaries. Chronic drug users in the criminal justice system pose risks to themselves and the general population through their commission of drug-related property and violent crime, as well as through the spread of infectious diseases, such as HIV and HCV. In this chapter, we review multinational evidence concerning the drug/crime relationship, the use of drugs within correctional settings, the consequences of drug use among offenders, and the intervention approaches for drug-involved offenders in custodial settings as well as those under community supervision. We conclude with several recommendations for practice and research that we consider to be important next steps in advancing this literature: (1) focus on implementation; (2) need for more randomized trials; (3) clarification of the role of coercion – when it helps, when it hurts; (4) distinguish “addicted offenders” from “offender addicts”; and (5) examine the use of depot medications for opiate-dependent offenders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 339.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Asscher JJ, Deković M, van der Laan PH, Prins P, van Arum S (2007) Implementing randomized experiments in criminal justice settings: an evaluation of multi-systemic therapy in the Netherlands. J Exp Criminol 3:113–129

    Article  Google Scholar 

  • Bahr SJ, Masters AL, Taylor BM (2012) What works in substance abuse treatment programs for offenders? Prison J 92(2):155–174

    Article  Google Scholar 

  • Baillargeon J, Giordano TP, Rich J, Wu Z, Wells K, Pollack BH, Paar DP (2009) Accessing antiretroviral therapy following release from prison. JAMA 301(8):848–857

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bayanzadeh SA, Bolhari J, Noori R, Lavasani F, Karimi E (2007) The role of pharmacotherapeutic and psychosocial interventions in reducing drug related harm among addict prisoners. J Iran Univ Med Sci 14(55):47–55, [In Farsi] Cited in Momtazi S and Noroozi A (this volume)

    Google Scholar 

  • Belenko S (1998) Research on drug courts: a critical review. Natl Drug Court Inst Rev 1(1):1–42

    Google Scholar 

  • Betteridge G, Jurgens R (2008) Opioid substitution therapy in prisons: reviewing the evidence. Canadian HIV/AIDS Legal Network, Canada, http://www.aidslaw.ca/publications/interfaces/downloadFile.php?ref=1293. Accessed 1 May 2013

  • Bewley-Taylor D, Hallam C, Allen R (2009) The incarceration of drug offenders: an overview. King’s College, London

    Google Scholar 

  • Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, Koepsell TD (2007) Release from prison – a high risk of death for former inmates. New Engl J Med 356(2):157–165

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bullock T (2003) Changing levels of drug use before, during and after imprisonment. In: Ramsay M (ed) Prisoners’ drug use and treatment: seven research studies. Home office research study 267. Home Office, London, pp 23–49

    Google Scholar 

  • Bureau of Justice Statistics (2002) Recidivism of prisoners released in 1994. GPO, Washington, DC

    Google Scholar 

  • Cartier J, Farabee D, Prendergast ML (2006) Methamphetamine use, violence, and recidivism among California parolees. J Interpers Violence 21:435–445

    Article  PubMed  Google Scholar 

  • Center on Addiction and Substance Abuse (CASA) (2010) Behind bars II: substance abuse in America’s prison population. CASA, New York

    Google Scholar 

  • Cornish JW, Metzger D, Woody GE, Wilson D, McLellan AT, Vandergrift B, O’Brien CP (1997) Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat 14:529–534

    Article  CAS  PubMed  Google Scholar 

  • Dolan K, Khoei EM, Brentari C, Stevens A (2007) Prisons and drugs: a global review of incarceration, drug use, and drug services. Beckley Foundation, London

    Google Scholar 

  • Farabee D, Prendergast ML, Cartier J, Wexler W, Knight K, Anglin MD (1999) Barriers to implementing effective correctional treatment programs. Prison J 79(2):150–162

    Article  Google Scholar 

  • Farnia M, Ebrahimi B, Shams A, Zamani S (2010) Scaling up methadone treatment for opioid-dependent prisoners in Iran. Int J Drug Policy 21:422–424

    Article  PubMed  Google Scholar 

  • Farrell M, Marsden J (2007) Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction 103:251–255

    Article  Google Scholar 

  • Farrington D, Welsh BC (2005) Randomized experiments in criminology: what have we learned in the past two decades? J Exp Criminol 1:9–38

    Article  Google Scholar 

  • Ferri M, Amato L, Davoli M (2006) Alcoholics anonymous and other 12-step programmes for alcohol dependence. Cochrane Database Syst Rev 3:CD005032, Wiley and Sons, London

    PubMed  Google Scholar 

  • Foster J, Brewer C, Steele T (2003) Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totaling 101 patients with a note on naltrexone blood levels. Addict Biol 8:211–217

    Article  CAS  PubMed  Google Scholar 

  • Friedmann P, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, Flynn PM, Welsh WN, Stein LAR, Sacks S, O’Connell DJ, Knudsen HK, Shafer MS, Hall E, Frisman LK (2012) Medication-assisted treatment in criminal justice agencies affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): availability, barriers and intentions. Subst Abus 33:9–18

    Article  PubMed Central  PubMed  Google Scholar 

  • Gendreau P, Goggin C, Smith P (1999) The forgotten issue in effective correctional treatment: program implementation. Int J Offender Ther Comp Criminol 43(2):180–187

    Article  Google Scholar 

  • Gillespie W (2005) A multilevel model of drug abuse inside prison. Prison J 85(2):223–246

    Article  Google Scholar 

  • Goldstein PJ (1985) The drugs/violence nexus: a tripartite conceptual framework. J Drug Issues 15:493–506

    Google Scholar 

  • Gordon MS, Kinlock TW, Schwartz RP, O’Grady KE (2008) A randomized clinical trial of methadone maintenance for prisoners: findings at 6-months post-release. Addiction 103:1333–1342

    Article  PubMed Central  PubMed  Google Scholar 

  • Gottfredson D, Exum L (2002) The Baltimore City drug court: one-year results from a randomized study. J Res Crime Delinq 39:337–356

    Article  Google Scholar 

  • Gottfredson DC, Kearley B, Najaka SS, Rocha C (2005) The Baltimore City drug treatment court: three-year self-report outcome study. Eval Rev 29(1):42–64

    Article  PubMed  Google Scholar 

  • Hawken A, Kleiman M (2009) Managing drug-involved probationers with swift and certain sanctions: evaluating Hawaii’s HOPE. NCJ 229023. National Institute of Justice, Washington

    Google Scholar 

  • Hough M (2002) Drug user treatment within a criminal justice context. Subst Use Misuse 37:985–996

    Article  PubMed  Google Scholar 

  • Inciardi JA, Lockwood D, Quinlan JA (1993) Drug use in prison: patterns, processes, and implications for treatment. J Drug Issues 23(1):119–130

    Google Scholar 

  • Kendall PRW, Pearce M (2000) Drug testing in Canadian jails: to what end? Can J Public Health 91(1):26–28

    CAS  PubMed  Google Scholar 

  • Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL (2011) Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet 377:1506–1513

    Article  CAS  PubMed  Google Scholar 

  • Landenberger NA, Lipsey MW (2005) The positive effects of cognitive-behavioral programs for offenders: a meta-analysis of factors associated with effective treatment. J Exp Criminol 1:451–476

    Article  Google Scholar 

  • Ling W, Wesson DR (2003) Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Drug Alcohol Depend 70(2):S49–S58

    Article  CAS  PubMed  Google Scholar 

  • Magill M, Ray L (2009) Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs 70:516–527

    Article  PubMed Central  PubMed  Google Scholar 

  • Mattick RP, Kimber J, Breen C, Davoli M (2008) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2:CD002207

    PubMed  Google Scholar 

  • Merrall LC, Kariminia A, Binswanger IA, Hobbs MS, Farrell M, Marsden J, Hutchinson SJ, Bird SM (2010) Meta-analysis of drug-related deaths soon after release from prison. Addiction 105:1545–1554

    Article  PubMed Central  PubMed  Google Scholar 

  • Momtazi S, Rawson R, Musavinasab N, Hamzehlu MB (2012) Methadone maintenance treatment program for drug abuse prisoners in Iran. Abstract book of the National Institute on Drug Abuse international forum. Palm Springs, California

    Google Scholar 

  • Mumola CJ, Karberg JC (2006) Drug use and dependence: state and federal prisoners, 2004. Office of Justice Programs, Bureau of Justice Statistics, Washington, DC

    Google Scholar 

  • Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD (2009) Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend 105:83–88

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Nurco DN, Hanlon TE, Kinlock TW, Duszynski KR (1988) Differential criminal patterns of narcotic addicts over an addiction career. Criminology 26:407–423

    Article  Google Scholar 

  • Oser CB, Knudsen HK, Staton-Tindall M, Taxman F, Leukefeld C (2009) Organizational-level correlates of the provision of detoxification services and medication-based treatment for substance abuse in correctional institutions. Drug Alcohol Depend 103(Suppl 1):S73–S81

    Article  PubMed Central  PubMed  Google Scholar 

  • Payne J, Gaffney A (2012) How much crime is drug or alcohol related? Self reported attributions of police detainees. Trends & issues in crime and criminal justice 439 http://www.aic.gov.au/publications/current%20series/tandi/421-440/tandi439.html. Accessed 1 May 2013

  • Pearson FS, Lipton DS (1999) A meta-analytic review of the effectiveness of corrections-based treatments for drug abuse. Prison J 79(4):384–410

    Article  Google Scholar 

  • Pernanen K, Cousineau M, Brochu S, Sun F (2002) Proportions of crimes associated with alcohol and other drugs in Canada. Canadian Centre on Substance Abuse, Ottawa

    Google Scholar 

  • Phipps P, Korinek K, Aos S, Lieb R (1999) Research findings on adult corrections programs: a review. Washington State Institute for Public Policy, Olympia

    Google Scholar 

  • Shewan D, Gemmell M, Davies JB (1994) Prison as a modifier of drug using behavior. Addict Res Theory 2(2):203–215

    Article  Google Scholar 

  • Sokolov BP, Schindler CW, Cadet JL (2004) Chronic methamphetamine increases fighting in mice. Pharmacol Biochem Behav 77:319–326

    Article  CAS  PubMed  Google Scholar 

  • Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH (2005) Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep 120(1):84–88

    PubMed Central  PubMed  Google Scholar 

  • Stover H, Michels II (2010) Drug use and opioid substitution treatment for prisoners. Harm Reduction J 7:17–24

    Article  Google Scholar 

  • Tardiff K, Gross E, Messner S (1986) A study of homicide in Manhattan, 1081. Am J Public Health 76:139–143

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Taxman F, Perdoni ML, Harrison L (2007) Drug treatment services for adult offenders: the state of the state. J Subst Abuse Treat 32:239–254

    Article  PubMed Central  PubMed  Google Scholar 

  • Vigdal GL, Stadler DW (1989) Controlling inmate drug use: cut consumption by reducing demand. Correct Today 51(3):96–97

    Google Scholar 

  • Wild TC, Roberts AB, Cooper EL (2002) Compulsory substance abuse treatment: an overview of recent findings and issues. Eur Addict Res 8:84–93

    Article  PubMed  Google Scholar 

  • Zurhold H, Stöver H, Haasen C (2004) Female drug users in European prisons – best practice for relapse prevention and reintegration. Centre for Interdisciplinary Addiction Research, University of Hamburg, Hamburg

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Farabee .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Italia

About this entry

Cite this entry

Farabee, D., Rawson, R.A., Gawad, T.A. (2015). Treatment in Criminal Justice Settings. In: el-Guebaly, N., Carrà, G., Galanter, M. (eds) Textbook of Addiction Treatment: International Perspectives. Springer, Milano. https://doi.org/10.1007/978-88-470-5322-9_112

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5322-9_112

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5321-2

  • Online ISBN: 978-88-470-5322-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics